Erschienen in:
01.03.2024 | Editorial
More than meets the eye: 2-[18F]FDG PET-based radiomics predicts lymph node metastasis in colorectal cancer patients to enable precision medicine
verfasst von:
Wenpeng Huang, Mai Hong Son, Le Ngoc Ha, Lei Kang, Weibo Cai
Erschienen in:
European Journal of Nuclear Medicine and Molecular Imaging
|
Ausgabe 6/2024
Einloggen, um Zugang zu erhalten
Excerpt
Colorectal cancer (CRC) ranks as the third most prevalent cancer and the fourth leading cause of cancer-related mortality worldwide [
1,
2]. Lymph node metastasis (LNM) stands as the primary route of metastasis in CRC, intricately influencing the surgical scope, the formulation of adjuvant chemotherapy programs, and the postoperative survival rates of patients [
3,
4]. Consequently, the accurate and comprehensive assessment of lymph node (LN) status is pivotal in CRC, holding the potential to optimize personalized therapy—often referred to as precision medicine—thus advancing individualized patient care. The conventional gold standard for diagnosing LNM involves preoperative invasive lymph node biopsy and pathology. However, the pathological examination has several limitations, including invasiveness, high cost, and susceptibility to sampling errors. …